Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 2012
Incorporation of transmembrane hydrophobic mutations in the TCR enhance its surface expression and T cell functional avidityAstar Haga-Friedman, Miryam Horovitz-Fried, Cyrille J CohenInternational Journal of Cancer|June 12, 2013
Enhanced antitumor activity mediated by human 4-1BB-engineered T cellsInbal Daniel-Meshulam, Miryam Horovitz-Fried, Cyrille J CohenOncoimmunology|May 17, 2017
The mutational status of p53 can influence its recognition by human T-cellsKaterina Shamalov, Shlomo N Levy, Miryam Horovitz-Fried, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 13, 2013
Human T cells engineered to express a programmed death 1/28 costimulatory retargeting molecule display enhanced antitumor activityChen Ankri, Katerina Shamalov, Miryam Horovitz-Fried, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2010
Selected murine residues endow human TCR with enhanced tumor recognitionGil Bialer, Miryam Horovitz-Fried, Shlomo Ya'acobi, et al.Oncotarget|November 29, 2014
An NCR1-based chimeric receptor endows T-cells with multiple anti-tumor specificitiesYair Tal, Shlomo Yaakobi, Miryam Horovitz-Fried, et al.ACS Nano|June 4, 2015
Nanomedicine for Cancer Immunotherapy: Tracking Cancer-Specific T-Cells in Vivo with Gold Nanoparticles and CT ImagingRinat Meir, Katerina Shamalov, Oshra Betzer, et al.The Journal of Clinical Investigation|September 22, 2015
Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytesCyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, et al.Pageof 1